C‐reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective coronary intervention
Open Access
- 1 April 2004
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 27 (4) , 211-216
- https://doi.org/10.1002/clc.4960270407
Abstract
Background: Both vascular inflammation as determined by C‐reactive protein (CRP) and extrinsic coagulation as measured by factor VII activity (F VII) may predict clinical restenosis rate in patients with stable angina pectoris undergoing elective percutaneous coronary intervention (PCI).Hypothesis: The primary objective of this study was to investigate the associations between baseline CRP levels, F VII activity, and restenosis rate after elective PCI in a 6‐month follow‐up period.Methods: This prospective study included 81 patients aged ≥19 years undergoing PCI for angiographically significant (⩾70%) stenosis, with or without stenting, and 49 controls. Factor VII activity and CRP were measured in samples collected at angiography and 16‐24 h post procedure after overnight fast. Successful PCI was defined as final diameter of < 50% with TIMI 3 flow and no complication within 1 h. After 6 months all patients who had undergone PCI were evaluated via a standardized questionnaire. Clinical restenosis was defined as the occurrence of a major adverse coronary events (MACE), within the follow‐up period.Results: Diagnostic angiography led to a significant increase in CRP levels after 16–20 h in patients with discrete CAD (n = 22) but not in patients without any signs of coronary atherosclerosis (n = 27). During a 6‐month follow‐up after PCI, 17 of 81 (21%) patients developed MACE. Tertiles of CRP levels independently predicted clinical restenosis, as it developed in 33.3% of patients with the highest CRP levels (0.7–4.8 mg/dl), in 16.6% of patients with second tertile CRP levels (0.23–0.69 mg/dl), and in 7.4% of patients with lowest tertile CRP levels (0.0–0.22 mg/dl). There was a significant difference in the restenosis rate between patients from the first and the third tertiles (p = 0.018). Successful PCI was associated with a significant decrease of mean CRP levels after 6 months, whereas PCI in patients suffering from MACE led to no change in CRP levels. There was no association between factor VII activity and clinical outcome after PCI, and F VII activity did not change over a 6‐month period.Conclusions: In patients with stable angina pectoris undergoing elective PCI, increased preprocedural and 6‐month follow‐up CRP plasma levels are associated with clinical restenosis. Factor VII plasma activity lacks such correlations.Keywords
This publication has 11 references indexed in Scilit:
- Relation of Inflammation and Benefit of Statins After Percutaneous Coronary InterventionsCirculation, 2003
- A Self-Fulfilling ProphecyCirculation, 2002
- The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplastyEuropean Heart Journal, 2002
- Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise testCoronary Artery Disease, 2002
- C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with anginaJournal of the American College of Cardiology, 2002
- Statin therapy, inflammation and recurrent coronary events in patients following coronary stent implantationJournal of the American College of Cardiology, 2001
- Tissue Factor Overexpression in Rat Arterial Neointima Models Thrombosis and Progression of Advanced AtherosclerosisCirculation, 2000
- Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantationThe American Journal of Cardiology, 2000
- Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable anginaThe American Journal of Cardiology, 1998
- Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994